Monopar Therapeutics MNPR
NASDAQ MNPR
$79.69 -0.31 (-0.39%)
As of: Sep 30, 2026 · 3:59 PM EDT

Monopar Therapeutics (MNPR) Preferred Shares (2016)

Updated

Monopar Therapeutics (MNPR) reported Preferred Shares of $116.00 for Q4 2016.

Analysis

Monopar Therapeutics (MNPR) Preferred Shares (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Monopar Therapeutics 683.40 Mn 401.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 116.00
API Access

Monopar Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=MNPR&period=max&api_key=YOUR_API_KEY